Research And Development Tenders

Improving Hygiene and COVID-19 Pandemic Control Measures

Operational Efficiency and Management Effectiveness Improvement of the Water Supply System

Dynamic Acquisition System for the Mechanical Workshop and Boiler Service for Work to be Carried out in the Facilities and Networks of Emacsa.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Eptinezumab (N02cd05) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Pimecrolimus (D11ah02) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Tolvaptan (G04bx21) as Part of a So-Called Open House Model.

Rv to Provide Prevention Measures in Accordance with Sections 20 Ff Sbg V, Oh Procedure

Medicines with the Active Ingredient Tacrolimus (Atc: L04ad02)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Iron (Ii) Sulfate (B03aa07) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Fingolimod (L04ae01) as Part of a So-Called Open House Model.